{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:19:19Z","timestamp":1785932359021,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s40266-019-00699-0","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T02:02:56Z","timestamp":1566439376000},"page":"991-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure"],"prefix":"10.1007","volume":"36","author":[{"given":"Joshua C.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fintelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohollah","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-2736","authenticated-orcid":false,"given":"Mary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"3","key":"699_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0420.2005.00422.x","volume":"83","author":"M Koksal","year":"2005","unstructured":"Koksal M, Ozdemir H, Kargi S, Yesilli C, Tomac S, Mahmutyazicioglu K, et al. The effects of sildenafil on ocular blood flow. Acta Ophthalmol Scand. 2005;83(3):355\u20139.","journal-title":"Acta Ophthalmol Scand"},{"issue":"30","key":"699_CR2","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.2174\/138161209789206971","volume":"15","author":"D Kouvelas","year":"2009","unstructured":"Kouvelas D, Goulas A, Papazisis G, Sardeli C, Pourzitaki C. PDE5 inhibitors: in vitro and in vivo pharmacological profile. Curr Pharm Des. 2009;15(30):3464\u201375.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"699_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1557988313480808","volume":"7","author":"E Damar","year":"2013","unstructured":"Damar E, Toklu Y, Tuncel A, Balci M, Asian Y, Simsek S, et al. Does therapeutic dose of sildenafil citrate treatment lead to central serious chorioretinopathy in patients with erectile dysfunction. Am J Mens Health. 2013;7(5):439\u201343.","journal-title":"Am J Mens Health"},{"key":"699_CR4","first-page":"237","volume-title":"Adler\u2019s physiology of the eye: clinical application","year":"2003","unstructured":"Kaufman PL, Alm A, Adler FH, editors. Adler\u2019s physiology of the eye: clinical application. 10th ed. St. Louis: Mosby; 2003. p. 237\u201371.","edition":"10"},{"issue":"5","key":"699_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1442-9071.2009.02070.x","volume":"37","author":"NM Kerr","year":"2009","unstructured":"Kerr NM, Danesh-Mayer HV. Phosphodiesterase inhibitors and the eye. Clin Exp Ophthalmol. 2009;37(5):514\u201323.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"699_CR6","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1167\/iovs.09-4862","volume":"51","author":"R Gerometta","year":"2010","unstructured":"Gerometta R, Alvarez LJ, Candia OA. Effects of sildenafil and tadalafil on intraocular pressure in sheep: implications for aqueous humor dynamics. Invest Ophthalmol Vis Sci. 2010;51(6):3139\u201344.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"699_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874364101004010052","volume":"4","author":"M Goel","year":"2010","unstructured":"Goel M, Picciani R, Lee RK, Bhattacharya SK. Aqueous humor dynamics: a review. Open Ophthalmol J. 2010;4:52\u20139.","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"699_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/B:INTE.0000031735.45526.1c","volume":"25","author":"SS Ermis","year":"2004","unstructured":"Ermis SS, Inan UU, Samli M, Ozturk F. Acute effects of sildenafil on Humphrey visual field and intraocular pressure. Int Ophthalmol. 2004;25(2):69\u201372.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"699_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/jop.2006.121","volume":"23","author":"P Taner","year":"2007","unstructured":"Taner P, Basar MM, Unal B, Batislam E. Effects of vardenafil on intraocular pressure and orbital hemodynamics. J Ocul Pharmacol Ther. 2007;23(3):275\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"Part 4","key":"699_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2001.163","volume":"15","author":"SO Dundar","year":"2001","unstructured":"Dundar SO, Dundar M, Kocak I, Dayanir Y, Ozkan SB. Effects of sildenafil on ocular haemodynamics. Eye. 2001;15(Part 4):507\u201310.","journal-title":"Eye"},{"issue":"6","key":"699_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9394(00)00944-2","volume":"131","author":"JE Grunwald","year":"2001","unstructured":"Grunwald JE, Siu KK, Jacob SS, Dupont J. Effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol. 2001;131(6):751\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"699_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0002-9394(00)00375-5","volume":"129","author":"T Yajima","year":"2000","unstructured":"Yajima T, Yajima Y, Koppiker N, Grunwald F, Laties AM. No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra). Am J Ophthalmol. 2000;129(5):675\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"699_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exer.2011.05.010","volume":"93","author":"R Gerometta","year":"2011","unstructured":"Gerometta R, Alvarez LJ, Candia OA. Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers. Exp Eye Res. 2011;93(1):103\u20137.","journal-title":"Exp Eye Res."},{"issue":"3","key":"699_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.ijir.3901416","volume":"18","author":"SO Dundar","year":"2006","unstructured":"Dundar SO, Dayanir Y, Topaloglu A, Dundar M, Kocak I. Effect of sildenafil on ocular hemodynamics in 3\u00a0months regular use. Int J Impot Res. 2006;18(3):282\u20136.","journal-title":"Int J Impot Res"},{"issue":"9","key":"699_CR15","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.19082\/5229","volume":"9","author":"A Nazari","year":"2017","unstructured":"Nazari A, Tabrizi YT, Mokhtaree M. Effect of periodic sildenafil dosage on intraocular pressure in patients with erectile dysfunction. Electr Phys. 2017;9(9):5229\u201332.","journal-title":"Electr Phys"},{"issue":"4","key":"699_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archophthalmol.2009.36","volume":"127","author":"WH Cordell","year":"2009","unstructured":"Cordell WH, Maturi R, Costigan TM, Marmor MF, Weleber KG, Coupland SG, et al. Retinal effects of 6\u00a0months of daily use of tadalafil or sildenafil. Arch Opthalmol. 2009;127(4):367\u201373.","journal-title":"Arch Opthalmol"},{"issue":"8","key":"699_CR17","doi-asserted-by":"publisher","first-page":"e0183388","DOI":"10.1371\/journal.pone.0183388","volume":"12","author":"SP Chen","year":"2017","unstructured":"Chen SP, Singh K, Lin SC. Use of phosphodiesterase inhibitors and prevalence of self-reported glaucoma in the United States. PLoS One. 2017;12(8):e0183388. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0183388\n                    \n                   (August 17,2017)).","journal-title":"PLoS One."},{"key":"699_CR18","first-page":"115","volume":"97","author":"AM Laties","year":"1999","unstructured":"Laties AM, Fraunfelder FT. Ocular safety of Viagra (sildenafil citrate). Trans Am Ophthalmol Soc. 1999;97:115\u201325.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"699_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0420.2006.00803.x","volume":"85","author":"B Ramasamy","year":"2007","unstructured":"Ramasamy B, Rowe F, Nayak H, Peckar C, Noonan C. Acute angle closure glaucoma following sildenafil citrate-aided sexual intercourse. Acta Ophthalmol Scand. 2007;85(2):229\u201330.","journal-title":"Acta Ophthalmol Scand."},{"issue":"20","key":"699_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","volume":"338","author":"I Goldstein","year":"1998","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338(20):1397\u2013404.","journal-title":"N Engl J Med."},{"key":"699_CR21","unstructured":"Optometric Clinical Practice Guideline. Care of the patient with open angle glaucoma, American Optometric Association. 2011. \n                    https:\/\/www.aoa.org\/documents\/optometrists\/CPG-9.pdf\n                    \n                  . Accessed 18 Apr 2019."},{"issue":"3","key":"699_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ajo.2014.05.029","volume":"158","author":"D Zhao","year":"2014","unstructured":"Zhao D, Cho J, Kim MH, Guallar E. The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol. 2014;158(3):615\u201327.","journal-title":"Am J Ophthalmol."},{"issue":"4","key":"699_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bjophthalmol-2015-306861","volume":"100","author":"N Gautam","year":"2016","unstructured":"Gautam N, Kaur S, Kaushik S, Pandav RSSS. Postural and diurnal fluctuations in intraocular pressure across the spectrum of glaucoma. Br J Ophthalmol. 2016;100(4):537\u201341.","journal-title":"Br J Ophthalmol."},{"key":"699_CR24","unstructured":"Jacobs, D. Open Angle glaucoma: Epidemiology, clinical presentation, and diagnosis. In: UpToDate. 2018. \n                    https:\/\/www.uptodate.com\/contents\/open-angle-glaucoma-epidemiology-clinical-presentation-and-diagnosis?search\u2009=\u2009Open%20Angle%20glaucoma:%20%20Epidemiology,%20clinical%20presentation,%20and%20diagnosis.&source\u2009=\u2009search_result&selectedTitle\u2009=\u20091~150&usage_type\u2009=\u2009default&display_rank\u2009=\u20091\n                    \n                  . Accessed 18 Apr 2019."},{"issue":"1","key":"699_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ophtha.2015.10.055","volume":"123","author":"B Prum","year":"2016","unstructured":"Prum B, Lim M, Mansberger S, Stein J, Moroi S, Gedde S, et al. Primary open-angle glaucoma suspect preferred practice pattern guidelines. Ophthalmology. 2016;123(1):112\u201351.","journal-title":"Ophthalmology."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00699-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00699-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:19:11Z","timestamp":1597965551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00699-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00699-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"22 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Joshua C. Baker, Robert Fintelmann, Roohollah Sharifi, and Mary Lee declare no conflicts of interest in the preparation or submission of this manuscript to Drugs and Aging for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding was received by any of the authors in the preparation or submission of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}